Subcutaneous Belimumab Demonstrates Consistent Steady-State Pharmacokinetics and is Well Tolerated in Paediatric Patients with SLE in China: An Open-Label Study
- DOI
- 10.1007/s40744-026-00878-7
- Published
- 2026-08-08
- Container
- Rheumatology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-026-00878-7,
title = {Subcutaneous Belimumab Demonstrates Consistent Steady-State Pharmacokinetics and is Well Tolerated in Paediatric Patients with SLE in China: An Open-Label Study},
author = {Caifeng Li and Junmei Zhang and Meiping Lu and Haiguo Yu and Li Sun and Qihua Feng and Zhihui Li and Jane Chen and Tiantian Liu and Junyi Wu and Xuan Zhou and Haomin Qiu},
year = {2026},
journal = {Rheumatology and Therapy},
doi = {10.1007/s40744-026-00878-7},
url = {https://doi.org/10.1007/s40744-026-00878-7}
}RIS
TY - JOUR TI - Subcutaneous Belimumab Demonstrates Consistent Steady-State Pharmacokinetics and is Well Tolerated in Paediatric Patients with SLE in China: An Open-Label Study AU - Caifeng Li AU - Junmei Zhang AU - Meiping Lu AU - Haiguo Yu AU - Li Sun AU - Qihua Feng AU - Zhihui Li AU - Jane Chen AU - Tiantian Liu AU - Junyi Wu AU - Xuan Zhou AU - Haomin Qiu PY - 2026 JO - Rheumatology and Therapy DO - 10.1007/s40744-026-00878-7 UR - https://doi.org/10.1007/s40744-026-00878-7 ER -
APA
Li, C., Zhang, J., Lu, M., Yu, H., Sun, L., Feng, Q., Li, Z., Chen, J., Liu, T., Wu, J., Zhou, X., & Qiu, H. (2026). Subcutaneous Belimumab Demonstrates Consistent Steady-State Pharmacokinetics and is Well Tolerated in Paediatric Patients with SLE in China: An Open-Label Study. Rheumatology and Therapy. https://doi.org/10.1007/s40744-026-00878-7
Source records
- crossref · retrieved 2026-09-26T05:42:06.375Z